» Articles » PMID: 27569560

CD4 and CD8 T Cells Mediate Distinct Lethal Meningoencephalitis in Mice Challenged with Tacaribe Arenavirus

Overview
Date 2016 Aug 30
PMID 27569560
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Neonates are at increased risk of viral encephalopathies that can result in neurological dysfunction, seizures, permanent disability and even death. The neurological damage results from the combined effect of the virus and the immune response it elicits, thus finding tools to facilitate viral clearance from central nervous system (CNS) while minimizing neuron damage remains a critical challenge. Neonatal mice inoculated intraperitoneally with Tacaribe virus (TCRV) develop seizures, hindlimb paralysis and death within 15 days of inoculation. TCRV localizes to the CNS within days of challenge, primarily infecting astrocytes in the cerebellum and brain stem. We show that infection leads to inflammation, T cell and monocyte infiltration into the cerebellar parenchyma, apoptosis of astrocytes, neuronal degeneration and loss of Purkinje cells. Infiltrating antigen-specific T cells fail to clear the virus but drive the disease, as T-cell-deficient CD3ɛ KO mice survive TCRV infection with minimal inflammation or clinical manifestations despite no difference in CNS viral loads in comparison with T-cell sufficient mice. CD8+ T cells drive the pathology, which even in the absence of CD4+ T-cell help, infiltrate the parenchyma and mediate the apoptotic loss of cerebellar astrocytes, neurodegeneration and loss of Purkinje cells resulting in loss of balance, paralysis and death. CD4+ T cells are also pathogenic inducing gliosis and inflammation in the cerebellum and cerebrum that are associated with wasting and death several weeks after CD4+ T-cell transfer. These data demonstrate distinct pathogenic effects of CD4+ and CD8+ T cells and identify them as possible therapeutic targets.

Citing Articles

Bystander activated CD8 T cells mediate neuropathology during viral infection via antigen-independent cytotoxicity.

Balint E, Feng E, Giles E, Ritchie T, Qian A, Vahedi F Nat Commun. 2024; 15(1):896.

PMID: 38316762 PMC: 10844499. DOI: 10.1038/s41467-023-44667-0.


Long-term persistence of infectious Zika virus: Inflammation and behavioral sequela in mice.

Ireland D, Manangeeswaran M, Lewkowicz A, Engel K, Clark S, Laniyan A PLoS Pathog. 2020; 16(12):e1008689.

PMID: 33301527 PMC: 7728251. DOI: 10.1371/journal.ppat.1008689.


CpG Oligonucleotides Protect Mice From Alphavirus Encephalitis: Role of NK Cells, Interferons, and TNF.

Manangeeswaran M, Lewkowicz A, Israely T, Ireland D, Verthelyi D Front Immunol. 2020; 11:237.

PMID: 32133008 PMC: 7040238. DOI: 10.3389/fimmu.2020.00237.


Beneficial and Detrimental Effects of Regulatory T Cells in Neurotropic Virus Infections.

Ciurkiewicz M, Herder V, Beineke A Int J Mol Sci. 2020; 21(5).

PMID: 32131483 PMC: 7084400. DOI: 10.3390/ijms21051705.


PD1CCR2CD8 T Cells Infiltrate the Central Nervous System during Acute Japanese Encephalitis Virus Infection.

Zhang F, Qi L, Li T, Li X, Yang D, Cao S Virol Sin. 2019; 34(5):538-548.

PMID: 31215000 PMC: 6814683. DOI: 10.1007/s12250-019-00134-z.


References
1.
Schmued L, Hopkins K . Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 2000; 874(2):123-30. DOI: 10.1016/s0006-8993(00)02513-0. View

2.
Herz J, Johnson K, McGavern D . Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J Exp Med. 2015; 212(8):1153-69. PMC: 4516789. DOI: 10.1084/jem.20142047. View

3.
Charrel R, de Lamballerie X . Arenaviruses other than Lassa virus. Antiviral Res. 2003; 57(1-2):89-100. DOI: 10.1016/s0166-3542(02)00202-4. View

4.
Lull M, Block M . Microglial activation and chronic neurodegeneration. Neurotherapeutics. 2010; 7(4):354-65. PMC: 2951017. DOI: 10.1016/j.nurt.2010.05.014. View

5.
Buchmeier M, Welsh R, Dutko F, Oldstone M . The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol. 1980; 30:275-331. DOI: 10.1016/s0065-2776(08)60197-2. View